Sangamo Therapeutics
SGMO
#10590
Rank
ยฃ22.48 M
Marketcap
ยฃ0.05429
Share price
0.00%
Change (1 day)
-86.70%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2026 (TTM): -ยฃ82.12 Million

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are ยฃ34.55 Million. In 2025 the company made an earning of -ยฃ79.24 Million a decrease over its 2024 earnings that were of -ยฃ72.23 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ82.12 Million3.64%
2025 -ยฃ79.24 Million9.71%
2024 -ยฃ72.23 Million-17.27%
2023 -ยฃ87.3 Million-40.88%
2022 -ยฃ0.15 Billion9.79%
2021 -ยฃ0.14 Billion41.52%
2020 -ยฃ95.04 Million23.17%
2019 -ยฃ77.16 Million36.33%
2018 -ยฃ56.6 Million36.89%
2017 -ยฃ41.35 Million-22.32%
2016 -ยฃ53.23 Million54.86%
2015 -ยฃ34.38 Million75.62%
2014 -ยฃ19.58 Million0.13%
2013 -ยฃ19.55 Million
2011 -ยฃ26.28 Million43.66%
2010 -ยฃ18.3 Million28.52%
2009 -ยฃ14.24 Million-23.55%
2008 -ยฃ18.62 Million2.45%
2007 -ยฃ18.18 Million19.5%
2006 -ยฃ15.21 Million50.78%
2005 -ยฃ10.09 Million75%
2004 -ยฃ5.77 Million-33.25%
2003 -ยฃ8.64 Million-62.27%
2002 -ยฃ22.89 Million102.82%
2001 -ยฃ11.29 Million23.21%
2000 -ยฃ9.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ19.05 B-23,648.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.66 B-8,336.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.19 B-1,571.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-ยฃ1.86 Billion 2,190.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ7.86 B-9,824.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ9.64 B-12,021.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
ยฃ0.63 B-888.30%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ0.28 B-449.52%๐Ÿ‡บ๐Ÿ‡ธ USA